
Cyril Amarchand Mangaldas advises Astec LifeSciences on INR 2,382 Million rights issue of equity shares
The equity shares issued pursuant to the rights issue commenced trading on BSE and NSE on July 31, 2025.
The equity shares issued pursuant to the rights issue commenced trading on BSE and NSE on July 31, 2025.
Cyril Amarchand Mangaldas advised Fusion Finance on its rights issue of partly paid-up equity shares
by Ananya Raghavendra†and Eshvar Girish††
Clarification on dispatch of notice under Section 62(2) of Companies Act, 2013 by listed companies for rights issue opening upto 31st July,